Hormonal Health

Kisspeptin

Kisspeptin-10 (Metastin, KISS1)

The upstream signal that controls the entire hormone cascade

Kisspeptin is a hypothalamic neuropeptide that sits upstream of GnRH — the master signal driving LH, FSH, testosterone, and oestrogen. Discovered in 2001 and actively researched at Imperial College London, kisspeptin is studied for fertility diagnostics, hypogonadism, menopausal hot flashes (KNDy neuron hyperactivity), and hormonal recovery protocols. This guide covers the research, dosing used in trials, mechanism, and Australian vendor options.

Kisspeptin illustration

Admin routes

Subcutaneous, Intravenous

Popularity

Niche

Side effects

Generally mild

Vendors

0 rated

Key benefits

1Stimulates natural testosterone and oestrogen production
2Preserves HPG axis function (unlike TRT)
3Potential fertility treatment for both men and women
4May help with post-cycle recovery
5Pulsatile dosing mimics natural hormone release
6No testicular suppression (unlike exogenous testosterone)

What to expect

1
Single dose

LH and testosterone pulse within 30–60 minutes

2
Week 1–2

Hormonal response measurable via blood work

3
Week 2–4

Sustained hormonal signalling improvements

4
Week 4+

Ongoing research - long-term protocols still being studied

Based on community reports and published research. Individual results vary significantly.

Dosing protocols

Hormonal support

Dose

100–400 mcg

Frequency

1–2 times daily (subcutaneous)

Duration

Research protocols vary

Dosing information is sourced from published research and community protocols. This is not a recommendation. Consult a healthcare professional.

Research status|Phase 2 clinical trials - active research at Imperial College London

Overview

Kisspeptin (also known as metastin) is a neuropeptide produced in the hypothalamus that controls the reproductive hormone cascade. It stimulates GnRH (gonadotropin-releasing hormone) neurons, which in turn drive LH and FSH release from the pituitary, ultimately controlling testosterone and oestrogen production. Discovered in 2003, kisspeptin has been identified as the 'master switch' of puberty and reproductive function. Research interest has grown rapidly for potential applications in fertility treatment, hypogonadism management (as an alternative to TRT), and post-cycle hormonal recovery.

How it works

Kisspeptin binds to the GPR54 (KISS1R) receptor on GnRH neurons in the hypothalamus, triggering pulsatile GnRH release. This stimulates the pituitary to release LH and FSH, which in turn stimulate testosterone (in men) and oestrogen/progesterone (in women) production. Unlike exogenous testosterone or HCG, kisspeptin works at the very top of the hormonal cascade, preserving the entire HPG (hypothalamic-pituitary-gonadal) axis rather than suppressing it. This makes it theoretically ideal for restoring natural hormonal function.

Side effects

Injection site irritation
mildCommon
Flushing and warmth
mildUncommon
Limited human safety data for long-term use
moderateRare

Research history

1996

Gene discovered as metastasis suppressor (originally KISS1)

2003

Identified as master regulator of reproductive hormone cascade

2010

Clinical studies demonstrate GnRH and testosterone stimulation in men

2018

Kisspeptin-54 shown to increase LH pulsatility in human trials

2023

Growing research interest for male fertility and PCOS applications

Kisspeptin vs TRT vs HCG

Testosterone replacement therapy (TRT) provides testosterone directly but suppresses the HPG axis, causing testicular atrophy and infertility. HCG mimics LH, maintaining testicular function but still bypassing the hypothalamus and pituitary. Kisspeptin works at the very top - stimulating the entire cascade naturally. This makes it the most physiological approach to raising testosterone, as it preserves pulsatile GnRH release, natural LH/FSH patterns, and testicular function. The trade-off: it may not produce testosterone levels as high as direct TRT, and research is still early.

Recommended products

Hand-picked for this compound. Ships via Amazon 🇺🇸

Affiliate links — small commission at no extra cost to you.All essentials →

References

  1. [1]Dhillo WS, et al. "Kisspeptin-54 stimulates the hypothalamic-pituitary gonadal axis in human males." Journal of Clinical Investigation, 2005.
  2. [2]Jayasena CN, et al. "The effects of kisspeptin-10 on reproductive hormone release." Journal of Clinical Endocrinology & Metabolism, 2011.

Frequently asked questions

Related peptides

Community experiences

Share your experience with Kisspeptin. Effects, side effects, protocol details - help others make informed decisions.

Write a review

Rating:

No community reviews yet. Be the first to share your experience with Kisspeptin.

Need to calculate your dose?

Use our free reconstitution calculator to work out syringe units for Kisspeptin.

Open Calculator

Found this useful?

Share this guide

Get the free Beginner Peptide Protocol

Which peptides to start with, what to avoid, and safe handling. Delivered to your inbox.

Disclaimer: This guide is for educational and informational purposes only. It is not medical advice. The dosing protocols listed are sourced from published research and community reports and do not constitute a recommendation. Always consult a qualified healthcare professional before using any peptide. Check your local regulations regarding peptide purchase and use.